Stemedica Treats First Patient with Ischemic Allogeneic Mesenchymal Stem Cells

Stemedica Cell Technologies Press Release The San Diego stem cell company Stemedica Cell Technologies, Inc reported treatment of its first patient as part of a 35 patient clinical trial in stroke patients. The study uses bone marrow stem cells that have been preconditioned with hypoxia and used in a non-matched manner. The trial is being…